Washington (ots/PRNewswire) - - Data presented at the joint annual meeting of ICAAC and IDSA - Results suggest candidate vaccine may be as effective as Prevnar for the seven shared serotypes, and provide expanded coverage for six additional serotypes - Wyeth on track to complete U.S. filing for ...
Maidenhead, England (ots/PRNewswire) - - Data From Another Study Supported the use of ENBREL for up to Five Years in Ankylosing Spondylitis Patients New safety and efficacy data for active ankylosing spondylitis (AS) patients treated with ENBREL(R) (etanercept) were presented at the American College of ...
Beijing (ots/PRNewswire) - New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of cardiovascular death, heart ...
Detroit (ots/PRNewswire) - Convergence Show -- Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the highly integrated driver ICs ATA6833 and ATA6834 for brushless DC motor applications such as fuel pumps, turbo chargers, or exhaust gas recirculation -- applications which are ...
San Jose, California (ots/PRNewswire) - - Improved accuracy increases energy availability up to 15% and additional monitoring functions ensure higher safety Atmel(R) Corporation (Nasdaq: ATML) announced today a family of single-chip Li-ion battery management devices. Combining Atmel's patented high ...
Berlin (ots/PRNewswire) - - Results of 5,993 Patient Study UPLIFT (Understanding Potential Long-term Impacts on Function with Tiotropium) Presented Today at European Respiratory Society Annual Congress - Not for U.S. Media Results of the UPLIFT trial, presented today at the European Respiratory ...
London (ots/PRNewswire) - - World Contraception Day 2008 Highlights Scale and Impact of Unplanned Pregnancy Today, international sexual and reproductive health experts and successful recording artist and media personality Kelly Osbourne, call for more action to address the burgeoning problem of ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A., Canada, and Japan - Favourable Safety and Efficacy Profile of Actilyse(R) Confirmed by ECASS 3 Study Investigating Treatment in an Extended Time Window up to 4.5 Hours After Symptom Onset First results from ECASS 3 ...
Collegeville, Pennsylvania (ots/PRNewswire) - - 85,000 Expected to Enroll in Phase 4 Study Initiated Pre-Registration - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the Community Acquired Pneumonia Immunization Trial in Adults a major study in adults of an investigational 13-valent conjugate vaccine designed to help prevent pneumococcal pneumonia -- the leading cause ...
Collegeville, Pennsylvania (ots/PRNewswire) - - First African Nation Plans to Phase in Routine Vaccination Program Against Pneumococcal Disease for Infants and Young Children - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that South Africa has initiated an immunization program against pneumococcal disease with PREVENAR(R) ...
Geneva (ots/PRNewswire) - - Study Highlights Underlying Reasons for why Patients are Missing Their Supplementation GENEVA, September 15 /PRNewswire/ -- New research published today at the annual meeting of the American Society for Bone and Mineral Research (ASBMR), Montréal, Canada, reveals that less ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 11.09.2008 november AG´s management and supervisory board suggest a capital decrease at an extraordinary annual meeting aiming at supporting november AG´s n-going financial restructuring. As ...
Paris (ots/PRNewswire) - - Abstracts 186 and 1003 Sanofi-aventis announced today that results from two studies, GINGER and LACE, presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) demonstrated that a basal-bolus insulin regimen with LANTUS(R) (insulin ...
Paris (ots/PRNewswire) - - Abstracts 185 and 1112 Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes (EASD) 44th Annual Meeting demonstrating that the "basal plus" insulin strategy ...
Bristol-Myers Squibb and AstraZeneca
Rome (ots/PRNewswire) - - FOR EUROPEAN MEDICAL MEDIA ONLY - New Data Presented for the First Time at EASD 2008 - Saxagliptin With Metformin as Initial Combination Therapy Lowered A1C - Improvements Demonstrated Across Key Measures of Glucose Control Studied in Treatment-Naïve People With Type 2 ...
Bristol-Myers Squibb and AstraZeneca
Rome (ots/PRNewswire) - - FOR EUROPEAN MEDICAL MEDIA ONLY - New Data Presented for the First Time at EASD 2008 - Saxagliptin With Metformin as Initial Combination Therapy Lowered A1C - Improvements Demonstrated Across Key Measures of Glucose Control Studied in Treatment-Naïve People With Type 2 ...
Munich, Germany (ots/PRNewswire) - - In spite of the success of therapies targeting LDL in lowering cardiovascular risk, a residual risk still remains Cardiologists in Europe agree that reducing LDL-cholesterol (LDL-C or "bad" cholesterol) levels is the most important factor in treating dyslipidemia (abnormal blood lipids) and reducing the risk of a ...
Munich, Germany (ots/PRNewswire) - - TRANSCEND(R), Parallel Trial to ONTARGET(R), Confirms Long-Term Protective Benefits and Excellent Tolerability Profile of Telmisartan 80mg(1) on Top of Current Best Standard of Care MUNICH, Germany, August 31 /PRNewswire/ -- - For non-US Healthcare Media The ...
Cork, Ireland (ots/PRNewswire) - -INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside ...
Indianapolis (ots/PRNewswire) - - Study with duloxetine evaluating long-term pain reduction in treatment of DPNP is first to exceed three months Duloxetine hydrochloride maintained pain reduction in the treatment of diabetic peripheral neuropathic pain (DPNP) for more than six months,(1) according to new ...
. Total Group revenues up 27.9 percent to EUR 719.5 million . After-tax profit doubles to EUR 37.2 million . Full-year profit forecast raised ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/Half-Year results Schrobenhausen, August 14, 2008 - (euro adhoc) - The global ...
Mexico City, Mexico (ots/PRNewswire) - - Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008 New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company's once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), provides long-term efficacy and tolerability in treatment-naïve adults ...
Barcelona, Spain (ots/PRNewswire) - - Analysis Confirms That Oral Xeloda is Superior to IV 5-FU - Not for US Media A pre-planned multivariate analysis of the five-year follow-up data shows that patients receiving chemotherapy after-surgery to treat colon cancer, are more likely to live longer when taking the chemotherapy pill Xeloda (capecitabine), compared to those receiving 5-FU/FA intravenous (IV) ...
Basel, Switzerland (ots/PRNewswire) - - Roche Also Announces Start of NCORE Study to Determine Best Length of Treatment in Patients who do not Experience a Rapid Response Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys ...
Berlin (ots/PRNewswire) - - For non-US Healthcare Media and non-UK Healthcare Media - New Studies Show Benefits of MICARDIS(R) (Telmisartan) in Combination With Amlodipine and Hydrochlorothiazide The results of two new studies of MICARDIS(R) (telmisartan) in free combination with amlodipine or fixed combination with hydrochlorothiazide (HCTZ) 25 mg ...
Berlin (ots/PRNewswire) - New results of the ADVANCE (Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR Controlled Evaluation) trial have been presented today at the European Society of Hypertension (ESH) and show that the antihypertensive Preterax - a fixed combination of the ACE-inhibitor perindopril and the diuretic indapamide - reduces the likelihood of new or worsening nephropathy (kidney damage) ...
European Network of Fibromyalgia Associations (ENFA)
Paris (ots/PRNewswire) - - Lack of Physician Education May Contribute to Problem A new global survey of fibromyalgia patients and physicians shows that fibromyalgia, a chronic widespread pain condition, results in poor quality of life and poses a financial burden on patients often resulting in an ...
Maidenhead, England (ots/PRNewswire) - - Study Results Provide Further Evidence That Early Treatment of Rheumatoid Arthritis With Enbrel(R) Plus Methotrexate in Moderate to Severe Patients can Stop the Disease From Progressing, and Helps Patients Return to More Normal and Productive Lives Data presented ...
Ingelheim, Germany (ots/PRNewswire) - - First Ever Study to Demonstrate Efficacy of Pramipexole in Treating RLS-Associated Limb Pain - For Healthcare Media Outside the U.S.A. A new study demonstrating that pramipexole (Mirapexin(R)/Sifrol(R)) can significantly reduce RLS-associated limb pain in ...
Barcelona (ots/PRNewswire) - - In Addition to Effects on Allergic Rhinitis (Hayfever), GRAZAX(R) Demonstrated Significant Reductions in Asthma Symptoms in Children Aged 5 to 16 Years Old ALK-Abelló today presented successful results from a new clinical trial, GT-12, designed to measure the impact of GRAZAX(R) on allergic rhinitis and allergic asthma. GT-12 ...